Number of the records: 1
formoterol fumarát
SYS d000068759 LBL 00000nz--a2200181n--4500 005 20250606221738.7 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D02.033.100.291.425 065 $a D02.092.063.291.425 066 $a 01 $c 03 150 $a formoterol fumarát $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a formoterol $2 slo 450 $w v $a eformoterol $2 slo 450 $w v $a aformoterol $2 slo 550 $7 sllk_us_auth*d000420 $Y Albuterol $w b $a albuterol 550 $7 sllk_us_auth*d000068656 $Y Mometasone Furoate $w b $a mometazón furoát 550 $7 sllk_us_auth*d001993 $Y Bronchodilator Agents $w P $a látky bronchodilatačné 550 $7 sllk_us_auth*d058666 $Y Adrenergic beta-2 Receptor Agonists $w P $a agonisty beta-2-adrenergických receptorov 550 $7 sllk_us_auth*d000420 $Y Albuterol $w p $a albuterol 550 $7 sllk_us_auth*d000068656 $Y Mometasone Furoate $w p $a mometazón furoát 665 $a 2016 (1976) $2 eng 680 9-
$i An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. $2 eng 750 -2
$a Formoterol Fumarate $2 eng 980 $x M
Number of the records: 1